News & Updates

Interested in learning more about Hyfe? Read about all of our news, announcements and updates here!

Image resource about Hyfe Cough Monitoring to be Primary Endpoint in Pivotal Clinical Trial for First Digital Therapeutic to Treat Chronic Cough

Hyfe Cough Monitoring to be Primary Endpoint in Pivotal Clinical Trial for First Digital Therapeutic to Treat Chronic Cough

Regulatory agreement, secured with partner KYORIN Pharmaceutical Co., Ltd., marks the first time Hyfe's automated CoughMonitor Suite will serve as a primary endpoint in a pivotal clinical trial - a precedent for objective digital endpoints in regulated drug and device development.

15.06.2026

Image resource about New Market Intelligence Report Reveals $15B Opportunity in Chronic Cough Therapeutics, With Zero FDA-Approved Competitors

NewsAnnouncementsPress Release

New Market Intelligence Report Reveals $15B Opportunity in Chronic Cough Therapeutics, With Zero FDA-Approved Competitors

Comprehensive Chronic Cough Report reveals $15B opportunity. 100M patients, zero FDA-approved drugs, positioning digital cough monitoring as essential pharma infrastructure.

20.01.2026

Image resource about Scoping Review in Lancet Digital Health Highlights the Importance of Objective Cough Counting Data in Disease Management

NewsPress Release

Scoping Review in Lancet Digital Health Highlights the Importance of Objective Cough Counting Data in Disease Management

Review including Hyfe research evaluates continuous digital cough monitoring as a practical way to address limitations of patient-reported cough data

13.01.2026

NewsPress Release

New Clinical Trial Evidence Validates Effectiveness of Hyfe’s Digital Chronic Cough Platform

Study results demonstrate digital Behavioral Cough Suppression Therapy reduced cough frequency by over 40% in patients with refractory and unexplained chronic cough.

16.10.2025

NewsPress Release

Hyfe to Launch World’s First Prescription Digital Therapeutic to Treat Chronic Cough

Strategic partnership with KYORIN Pharmaceuticals aims to improve outcomes and expand treatment access to millions impacted by chronic cough globally.

24.02.2025

NewsAnnouncements

Hyfe and ActiGraph Partner to Deliver Continuous Cough Monitoring on the LEAP Platform

Hyfe’s AI-powered cough monitoring is now available on Actigraph’s FDA-cleared LEAP wearable, enabling continuous, privacy-preserving cough tracking alongside key health biomarkers

28.01.2025

$Image resource about Sensory Cloud Inc. and Hyfe Inc. Release Study on Inhaled Treatment for Refractory Chronic Cough$

NewsPress Release

Sensory Cloud Inc. and Hyfe Inc. Release Study on Inhaled Treatment for Refractory Chronic Cough

Clinical Trial Results Demonstrate Alkaline Magnesium-Based Salt Aerosol Reduced Cough Frequency by up to 35% in Refractory Chronic Cough Patients with Cough Counts Measured Continuously by AI-Powered tech

29.10.2024

NewsPress Release

Hyfe's AI-Powered Cough Tracker Contributes to Breakthrough Study at the University of Navarra

Hyfe's cough tracker was used in study by University of Navarra, revealing significant variability in cough patterns. This breakthrough highlights potential for continuous, objective chronic cough monitoring.

07.10.2024

NewsPress Release

Wellness App CoughPro Unveils Groundbreaking Cough Management Feature

CoughPro app introduces the world’s first digital Cough Management feature, offering AI-driven solutions for millions suffering from chronic cough.

09.09.2024

NewsPress Release

New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators

Research demonstrates the accuracy of Hyfe’s automated cough monitoring process and is the first to observe differences in type and length of cough between men and women.

12.12.2023

Image resource about Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management

NewsAnnouncements

Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management

AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.

06.12.2023

NewsAnnouncements

Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection

Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.

15.08.2023

Image resource about Hyfe AI Announces New Remote Cough Monitoring Integration, Aiding to Reduce Patient Hospitalization and Improve Virtual Care

NewsPress Release

Hyfe AI Announces New Remote Cough Monitoring Integration, Aiding to Reduce Patient Hospitalization and Improve Virtual Care

Studies show remote patient monitoring technology better predicts cough exacerbations to ultimately improve quality of life and reduce healthcare costs for patients with chronic cough.

19.07.2023

NewsPress Release

Hyfe Announces Plans to Launch Digital Therapeutic for Chronic Coughers

Hyfe is expanding into chronic cough treatment with the world's first digital therapeutic for cough, using a proprietary model that combines real time cough frequency with cough suppression therapy.

19.05.2023

NewsPress Release

Hyfe is Listed on CB Insights List of the Most Promising Digital Health Companies

150 winners selected out of 13,000 private companies; Hyfe recognized for contributions in screening, monitoring and diagnostics technologies

07.12.2022

NewsAnnouncements

Hyfe Joins Forces with Merck to Deploy AI Cough-detection Technology

Hyfe has entered into an agreement with Merck, to integrate its artificial intelligence-powered (AI) cough tracker technology into Merck’s consumer disease educational efforts.

19.07.2022

Image resource about Press Release: Hyfe Deploys Artificial Intelligence-Powered Technology to Monitor, Screen and Diagnose Respiratory Illnesses

News

Press Release: Hyfe Deploys Artificial Intelligence-Powered Technology to Monitor, Screen and Diagnose Respiratory Illnesses

Leader in acoustic epidemiology empowers health care providers, researchers, pharmaceutical companies, and patients with cough detection and classification platform

13.05.2022

NewsAnnouncements

Scientist use Hyfe to to track cough in Long Covid

Scientists use Hyfe to confirm that continuous cough monitoring for Long COVID was more sensitive in evaluating cough variability and response to treatment compared to patient reported outcomes.

02.05.2022

Image resource about Dr. Peter Small, Hyfe, Inc. Chief Medical Officer has Addressed the G20 meeting in Indonesia on the critical impact of digital innovation in combating Tuberculosis

NewsPress Release

Dr. Peter Small, Hyfe, Inc. Chief Medical Officer has Addressed the G20 meeting in Indonesia on the critical impact of digital innovation in combating Tuberculosis

Dr. Peter Small, Hyfe Chief Medical Officer has delivered deliver an intervention to the G20 Meeting in Yogyakarta, Indonesia, on the role of digital innovation in addressing public health crises.

30.03.2022

NewsPress Coverage

Hyfe in the Wall Street Journal: Coughs say a lot about your health, if your smartphone is listening

With apps and artificial intelligence, researchers want to use the cough to better diagnose asthma, Covid-19 and other respiratory illnesses

11.09.2021

Load 3 more

Showing 20 of 23

News Insights